Response to “HLA Allelic Variants and Carbamazepine‐Induced Hypersensitivity”

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|93|5|387-387

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.93, Iss.5, 2013-05, pp. : 387-387

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HLA Allelic Variants and Carbamazepine‐Induced Hypersensitivity

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 5, 2013-05 ,pp. : 386-387

John Wiley & Sons Inc

Access to resources Recommend Favorite

HLA-B genotyping to detect carbamazepine-induced Stevens-Johnson syndrome: implications for personalizing medicine

By Hung Shuen-Iu   Chung Wen-Hung   Chen Yuan-Tsong  

Personalized Medicine, Vol. 2, Iss. 3, 2005-08 ,pp. : 225-237

Future Medicine

Access to resources Recommend Favorite

HLA‐A*31:01 and HLA‐B*15:02 as Genetic Markers for Carbamazepine Hypersensitivity in Children

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 94, Iss. 1, 2013-07 ,pp. : 142-149

John Wiley & Sons Inc

Access to resources Recommend Favorite

HLA and Delayed Drug-Induced Hypersensitivity

By  

International Archives of Allergy and Immunology, Vol. 170, Iss. 3, 2016-08 ,pp. : 163-179

Karger

Access to resources Recommend Favorite

Carbamazepine-Induced Immune Thrombocytopenia in a 12-Year-Old Female

By  

Acta Haematologica, Vol. 100, Iss. 2, 1998-10 ,pp. : 104-105

Karger

Access to resources Recommend Favorite